Acute Budd–Chiari syndrome due to a simple liver cyst

Long, Jennifer; Vaughan-Williams, Hannah; Moorhouse, Joshua; Sethi, Harsheet; Kumar, Naveen

doi:10.1308/003588414x13824511649698

Cited by 17 publications

(11 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 3 , 4 Congenital cysts are more common in females of ages 40–70, whereas acquired cysts (including hydatid, traumatic and inflammatory cysts) occur more commonly in males of ages 30–50. 1 , 2 Mortality is generally low; 5 however, the mortality rate ranges according to etiology of the cyst, and increases when cyst complications develop.…”

Section: Epidemiologymentioning

confidence: 99%

“…Several other rarer complications have been reported only in case reports. Long et al 5 reports a case of a 66-year-old female with Budd-Chiari syndrome secondary to a rapidly enlarging cyst obstructing the hepatic vein. 5 Another single case report described an inferior vena cava (IVC) thrombus caused by external pressure on the IVC from a simple hepatic cyst.…”

Section: Complications Of Cystsmentioning

confidence: 99%

See 1 more Smart Citation

Differentiating Cystic Liver Lesions: A Review of Imaging Modalities, Diagnosis and Management

Mavilia¹,

Pakala²,

Molina³

et al. 2018

Journal of Clinical and Translational Hepatology

View full text Add to dashboard Cite

Hepatic cysts (HCs) are frequently discovered incidentally on abdominal imaging. The prevalence of HCs has been reported as high as 15–18% in the United States. Although most cysts are benign, some are malignant or premalignant. It is important to diagnose cystic lesions in order to properly manage them. Imaging with conventional ultrasound, computed tomography, magnetic resonance imaging, or contrast-enhanced ultrasound can be used to further characterize and diagnose HCs. Ultrasound is typically the first-line imaging modality, whereas more advanced imaging can help narrow down the specific lesion. Contrast-enhanced ultrasound is a newer modality, recently approved in the United States, which offers non-invasive evaluation in real-time. The first step in diagnosis is stratifying risk by differentiating simple and complex cysts. There are several features that can help identify HCs, including septae, mural consistency, calcifications, and quality of cystic fluid. Simple cysts are mainly congenital cysts, but also occur in polycystic liver disease. Complex cysts include mucinous neoplasms, echinococcal cysts, hemorrhagic cysts, cystic hepatocellular carcinoma and other rare lesions. Treatment is indicated in symptomatic cysts or those suspicious for malignant or premalignant features. Treatment modalities include fenestration, aspiration sclerotherapy, or surgical resection.

show abstract

Section: Epidemiologymentioning

confidence: 99%

Section: Complications Of Cystsmentioning

confidence: 99%

Differentiating Cystic Liver Lesions: A Review of Imaging Modalities, Diagnosis and Management

Mavilia¹,

Pakala²,

Molina³

et al. 2018

Journal of Clinical and Translational Hepatology

View full text Add to dashboard Cite

show abstract

“…liver transplantation, liver resection or cardiac surgery), extrinsic compression (i.e. hydatid cyst of the liver, polycystic liver disease, sarcoid granulomas or inflammatory pseudo‐tumour of the liver) or tumour invasion (i.e. hepatocellular carcinoma or adrenocortical carcinoma) are considered as secondary BCS.…”

Section: Introductionmentioning

confidence: 99%

Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China

Qi¹,

Han²,

Guo³

et al. 2016

Aliment Pharmacol Ther

View full text Add to dashboard Cite

We examined the differences in the aetiological distribution of BCS between the West and China. Several recommendations should be considered in Chinese BCS patients: (i) screening for hyperhomocysteinaemia and MTHFR mutation should be regularly performed; (ii) screening for MPNs, PNH, and anti-phospholipid syndrome should be selectively performed; (iii) inherited anti-thrombin, protein C, and protein S deficiencies should be actively explored; (iv) screening for FVL and prothrombin G20210A mutations may be unnecessary; and (v) the clinical significance of pregnancy and puerperium, poverty with bacterial infections and unsanitary environments, and family history as possible risk factors should never be neglected.

show abstract

“…The etiology of primary BCS remains unclear, but the involvement of thrombus, abnormal angioplasty, abnormal blood coagulation, and myeloproliferative disorder has been suggested . The causes of secondary BCS include liver tumors . Hepatocellular carcinoma may develop in advanced cases …”

Section: Guidelines For Diagnosis Of Aberrant Portal Hemodynamicsmentioning

confidence: 99%

“…5, The causes of secondary BCS include liver tumors. [102][103][104] Hepatocellular carcinoma may develop in advanced cases. 5,14…”

Section: Guidelines For Diagnosis Of Bcs Disease Entity and Symptomsmentioning

confidence: 99%

Diagnosis and treatment guidelines for aberrant portal hemodynamics

Furuichi

Tanaka

Takikawa

et al. 2017

Hepatology Research

View full text Add to dashboard Cite

Idiopathic portal hypertension (IPH), causing aberrant portal hemodynamics, is a disease with an as yet unidentified cause and no established treatment protocol. The Japanese research group on IPH in Japan was set up in 1975 by the Ministry of Health, Labor and Welfare. Extrahepatic portal obstruction and Budd-Chiari syndrome (BCS) have since been added to the group's research subjects. The aims of the research group are to accurately evaluate the current status of the three diseases in Japan, elucidate their etiology and pathogenesis, and develop new treatments. Due to the long-term efforts of the Japanese research group, aberrant portal hemodynamics has been investigated in a variety of aspects, from epidemiological and pathological studies to molecular biology analyses. As a result, it has been shown that there are abnormal genes in the liver, specific for IPH. In addition, pathological findings of BCS were internationally compared and the difference in findings between Japan and Europe (or North America) has been clarified. Furthermore, it was found that complication rates of hepatocellular carcinoma in BCS were higher in Japan. Based on the research, "Diagnosis and treatment of aberrant portal hemodynamics (2001)", including diagnostic criteria for aberrant portal hemodynamics, was published in 2001. In 2013, it was revised to "Diagnosis and treatment guidelines for aberrant portal hemodynamics (2013)" after the incorporation of diagnosis and treatment in accordance with its current status.

show abstract

Acute Budd–Chiari syndrome due to a simple liver cyst

Cited by 17 publications

References 6 publications

Differentiating Cystic Liver Lesions: A Review of Imaging Modalities, Diagnosis and Management

Differentiating Cystic Liver Lesions: A Review of Imaging Modalities, Diagnosis and Management

Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China

Diagnosis and treatment guidelines for aberrant portal hemodynamics

Contact Info

Product

Resources

About